Influence of contrast-enhanced CT and MRI with or without SPIO particles on therapy and therapy costs for patients with focal liver disease.

被引:11
作者
Helmberger, T
Gregor, M
Holzknecht, N
Rau, H
Scheidler, J
Reiser, M
机构
[1] Ludwig Maximilians Univ Klinikum, Inst Klin Radiol, D-81377 Munich, Germany
[2] Ludwig Maximilians Univ Klinikum, Chirurg Klin & Poliklin, D-81377 Munich, Germany
来源
ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN | 2000年 / 172卷 / 03期
关键词
diagnostic efficacy; contrast-enhanced spiral CT; MR imaging; ferumoxide; liver lesions;
D O I
10.1055/s-2000-12054
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: Evaluation of the diagnostic efficacy and cost-benefit of contrast enhanced CT (CT) and MRI pre- and post-SPIO-particles in focal hepatic disease with consideration of therapeutic outcome. Methods: In 52 patients with the suspicion of primary or secondary hepatic malignancy, biphasic spiral CT and breathhold gradient-echo T-1- and fast spin-echo T-2-weighted MRI pre- and post-ferumoxide administration (1.5 T, body-phased-array coil) were compared. The number of hepatic lesions and the related diagnoses resulting from each imaging modality were recorded and statistically correlated to the final diagnoses established by biopsy/OP (34/ 52), long term follow-up of 12 months (18/52), and a consensus reading of all imaging modalities considering all clinical imaging information. The most likely induced therapy resulting from each imaging test was correlated to the final therapy. Based on data from the hospitals accountants, the therapy-related costs were estimated without hospitalization costs. Results: In 34/52 (65.4%) of the cases the correct diagnosis was primarily stated by CT (sensitivity [se.] 85.2%, specificity [sp.] 44.0%). In additional 10/52 of the cases unenhanced MRI (se. 91.4%, sp. 75.0%) enabled correct diagnoses, and in another 6 cases the diagnosis was established only by SPIO-MRI (se. 100%, sp. 86.7%). Considering the possible therapeutic recommendation arising from each modality, CT would have induced needles therapy costs of 191,042 DM, unenhanced MRI of 171,035 DM, and SPIO-MRI of 7,311 DM. In comparison to the real therapy costs of 221,873 DM, this would have corresponded to an unnecessary increase of therapy costs of 86.1%, 77.1%, and 3.3%, respectively. In two cases (1 hemangioma, 1 regenerative nodule) all modalities failed, causing unnecessary surgery in one patient. Discussion: In this problem-oriented scenario unenhanced and SPIO-enhanced MRI proved to be superior to CT regarding diagnostic efficacy. The cost-benefit resulted mainly due to preserving patients from unnecessary surgical procedures.
引用
收藏
页码:251 / 259
页数:9
相关论文
共 29 条
[1]   IMAGING AND BIOPSY OF SUSPECTED HEPATIC HEMANGIOMAS [J].
BAKER, ME .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1994, 163 (05) :1261-1261
[2]  
BARTOLOZZI C, 1996, ACAD RADIOL, V3, P57
[3]   LIVER METASTASES - SAFETY AND EFFICACY OF DETECTION WITH SUPERPARAMAGNETIC IRON-OXIDE IN MR-IMAGING [J].
BELLIN, MF ;
ZAIM, S ;
AUBERTON, E ;
SARFATI, G ;
DURON, JJ ;
KHAYAT, D ;
GRELLET, J .
RADIOLOGY, 1994, 193 (03) :657-663
[4]  
Biggs C G, 1994, Curr Opin Gen Surg, P94
[5]  
BLACK WC, 1996, JMRI-J MAGN RESON IM, V1, P1
[6]  
BONSEL GJ, 1990, TRANSPLANT P, V22, P1481
[7]   Diagnostics of malignant liver tumours by MRI, CT and CTAP in cirrhosis patients. [J].
Born, M ;
Layer, G ;
Kreft, B ;
Schwarz, N ;
Schild, H .
ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN, 1998, 168 (06) :567-572
[8]  
EVENS RG, 1991, CANCER, V67, P1245, DOI 10.1002/1097-0142(19910215)67:4+<1245::AID-CNCR2820671522>3.0.CO
[9]  
2-H
[10]   THE EFFICACY OF DIAGNOSTIC-IMAGING [J].
FRYBACK, DG ;
THORNBURY, JR .
MEDICAL DECISION MAKING, 1991, 11 (02) :88-94